Targeting CLDN3 Enhances PD-1 Blockade Efficacy in Gastric Cancer by Disrupting the NF-κB/p65-CXCL1-PD-L1 Immune Evasion Axis.
- DOI
- 10.1016/j.jbc.2026.113717
- Published
- 2026 Nov 4
- Container
- The Journal of biological chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jbc.2026.113717,
title = {Targeting CLDN3 Enhances PD-1 Blockade Efficacy in Gastric Cancer by Disrupting the NF-κB/p65-CXCL1-PD-L1 Immune Evasion Axis.},
author = {Li X and He P and Gu Y and Cui R and Ma L and Li X and Li Y},
year = {2026},
journal = {The Journal of biological chemistry},
doi = {10.1016/j.jbc.2026.113717},
url = {https://doi.org/10.1016/j.jbc.2026.113717}
}RIS
TY - JOUR TI - Targeting CLDN3 Enhances PD-1 Blockade Efficacy in Gastric Cancer by Disrupting the NF-κB/p65-CXCL1-PD-L1 Immune Evasion Axis. AU - Li X AU - He P AU - Gu Y AU - Cui R AU - Ma L AU - Li X AU - Li Y PY - 2026 JO - The Journal of biological chemistry DO - 10.1016/j.jbc.2026.113717 UR - https://doi.org/10.1016/j.jbc.2026.113717 ER -
APA
X, L., P, H., Y, G., R, C., L, M., X, L., & Y, L. (2026). Targeting CLDN3 Enhances PD-1 Blockade Efficacy in Gastric Cancer by Disrupting the NF-κB/p65-CXCL1-PD-L1 Immune Evasion Axis.. The Journal of biological chemistry. https://doi.org/10.1016/j.jbc.2026.113717
Source records
- pubmed · retrieved 2026-11-10T12:45:29.331Z